Automated calculation of point A coordinates for CT-based high-dose-rate brachytherapy of cervical cancer

被引:1
|
作者
Kang, Hyejoo [1 ]
Padilla, Laura [2 ]
Hasan, Yasmin [3 ]
Ai-Hallaq, Hania [3 ]
机构
[1] Loyola Med, Dept Radiat Oncol, Maywood, IL USA
[2] Virginia Commonwealth Univ Hlth Syst, Dept Radiat Oncol, Richmond, VA USA
[3] Univ Chicago, Dept Radiat & Cellular Oncol, 5758 S Maryland Ave MC 9006, Chicago, IL 60637 USA
关键词
brachytherapy; automation; dose calculation point; image-guided brachytherapy; cervical cancer; FAILURE MODES; EFFICIENCY; CARCINOMA; SOCIETY; RECOMMENDATIONS; VOLUME;
D O I
10.5114/jcb.2017.69397
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The goal is to develop a stand-alone application, which automatically and consistently computes the coordinates of the dose calculation point recommended by the American Brachytherapy Society (i.e., point A) based solely on the implanted applicator geometry for cervical cancer brachytherapy. Material and methods: The application calculates point A coordinates from the source dwell geometries in the computed tomography (CT) scans, and outputs the 3D coordinates in the left and right directions. The algorithm was tested on 34 CT scans of 7 patients treated with high-dose-rate (HDR) brachytherapy using tandem and ovoid applicators. A single experienced user retrospectively and manually inserted point A into each CT scan, whose coordinates were used as the "gold standard" for all comparisons. The gold standard was subtracted from the automatically calculated points, a second manual placement by the same experienced user, and the clinically used point coordinates inserted by multiple planners. Coordinate differences and corresponding variances were compared using nonparametric tests. Results: Automatically calculated, manually placed, and clinically used points agree with the gold standard to < 1 mm, 1 mm, 2 mm, respectively. When compared to the gold standard, the average and standard deviation of the 3D coordinate differences were 0.35 +/- 0.14 mm from automatically calculated points, 0.38 +/- 0.21 mm from the second manual placement, and 0.71 +/- 0.44 mm from the clinically used point coordinates. Both the mean and standard deviations of the 3D coordinate differences were statistically significantly different from the gold standard, when point A was placed by multiple users (p < 0.05) but not when placed repeatedly by a single user or when calculated automatically. There were no statistical differences in doses, which agree to within 1-2% on average for all three groups. Conclusions: The study demonstrates that the automated algorithm calculates point A coordinates consistently, while reducing inter-user variability. Point placement using the algorithm expedites the planning process and minimizes associated potential human errors.
引用
收藏
页码:354 / 358
页数:5
相关论文
共 50 条
  • [21] CONCURRENT CHEMORADIOTHERAPY WITH HIGH-DOSE-RATE BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER
    Kim, Y. S.
    Kim, J. H.
    Lee, S. W.
    Yoon, S. M.
    Ahn, S. D.
    Choi, E. K.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S310 - S310
  • [22] Biological Planning for High-Dose-Rate Brachytherapy: Application to Cervical Cancer Treatment
    Lee, Eva K.
    Yuan, Fan
    Templeton, Alistair
    Yao, Rui
    Kiel, Krystyna
    Chu, James C. H.
    INTERFACES, 2013, 43 (05) : 462 - 476
  • [23] Pain in High-Dose-Rate Brachytherapy for Cervical Cancer: A Retrospective Cohort Study
    Becerra-Bolanos, Angel
    Jimenez-Gil, Miriam
    Federico, Mario
    Dominguez-Diaz, Yurena
    Valencia, Lucia
    Rodriguez-Perez, Aurelio
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (08):
  • [24] Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning
    Batchelar, Deidre
    Gaztanaga, Miren
    Schmid, Matt
    Araujo, Cynthia
    Bachand, Francois
    Crook, Juanita
    BRACHYTHERAPY, 2014, 13 (01) : 75 - 79
  • [25] Multifractionated high-dose-rate brachytherapy with concomitant daily teletherapy for cervical cancer
    Han, I
    Malviya, V
    Chuba, P
    Orton, C
    Devi, S
    Deppe, G
    Malone, J
    Christensen, C
    Ahmad, K
    Kim, Y
    Porter, A
    GYNECOLOGIC ONCOLOGY, 1996, 63 (01) : 71 - 77
  • [26] Posttraumatic Stress Disorder After High-Dose-Rate Brachytherapy for Cervical Cancer
    Whitley, Alexander C.
    Kim, Robert Y.
    Shelton, Richard C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (02): : 468 - 468
  • [27] High-Dose-Rate Interstitial Brachytherapy for Cervical Cancer - The More Catheters the Merrier?
    Patel, S.
    Jani, S.
    Pinnaduwage, D.
    Kramer, D.
    Ellefson, S. T.
    Sorensen, S. P.
    Diaz, A. Z.
    Thawani, N.
    Srivastava, S. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E707 - E707
  • [28] Towards Enabling Ultrasound Guidance in Cervical Cancer High-Dose-Rate Brachytherapy
    Wong, Adrian
    Sojoudi, Samira
    Gaudet, Marc
    Yap, Wan Wan
    Chang, Silvia D.
    Abolmaesumi, Purang
    Aquino-Parsons, Christina
    Moradi, Mehdi
    MEDICAL IMAGING 2014: IMAGE-GUIDED PROCEDURES, ROBOTIC INTERVENTIONS, AND MODELING, 2014, 9036
  • [29] Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer
    Stewart, Alexandra J.
    Viswanathan, Akila N.
    CANCER, 2006, 107 (05) : 908 - 915
  • [30] Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy
    Wang, Tonghe
    Press, Robert H.
    Giles, Matt
    Jani, Ashesh B.
    Rossi, Peter
    Lei, Yang
    Curran, Walter J.
    Patel, Pretesh
    Liu, Tian
    Yang, Xiaofeng
    BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1097):